Results 51 to 60 of about 3,176,059 (188)

Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses

open access: yesBMJ Open, 2021
Objectives To compare costs associated with different models of outpatient parenteral antimicrobial therapy (OPAT) delivery with costs of inpatient (IP) care across key infection groups managed via OPAT in the UK.Design A cost-minimisation design was ...
Mark Gilchrist   +2 more
doaj   +1 more source

Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers

open access: yesTherapeutic Advances in Infectious Disease, 2023
Background: Outpatient Parenteral Antimicrobial Therapy (OPAT) is considered a patient-friendly and cost-effective practice. Patients in the OPAT service can be at risk for developing adverse events.
Moska Hassanzai   +7 more
doaj   +1 more source

Continuous Intravenous Acyclovir as Outpatient Parenteral Antimicrobial Therapy for HSV and VZV Neurological Infections: A Case Series With Pharmacokinetic and Cost Evaluation, and Review of Literature

open access: yesReviews in Medical Virology, Volume 36, Issue 6, November 2026.
ABSTRACT Varicella zoster virus (VZV) and herpes simplex virus (HSV) are major causes of viral meningitis and encephalitis. Standard intermittent intravenous acyclovir requires hospitalisation, reducing patient comfort and prolonging admissions. Continuous infusion may maintain therapeutic plasma and cerebrospinal fluid (CSF) concentrations while ...
Irene G. Manders   +7 more
wiley   +1 more source

Outpatient Parenteral Antimicrobial Therapy Practices among Adult Infectious Disease Physicians [PDF]

open access: yes, 2014
Objective. To identify current outpatient parenteral antibiotic therapy practice patterns and complications. Methods. We administered an 11-question survey to adult infectious disease physicians participating in the Emerging Infections Network (EIN), a ...
Babcock, Hilary M   +7 more
core   +2 more sources

Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections

open access: yesMycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Background Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin with once‐weekly dosing, to address some limitations of current treatments for Aspergillus infections.
Neil Stone   +9 more
wiley   +1 more source

Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study. [PDF]

open access: yesInfection
Schmidt-Hellerau K   +15 more
europepmc   +2 more sources

An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy

open access: yesTherapeutic Advances in Infectious Disease, 2023
Background: Outpatient parenteral antimicrobial therapy (OPAT), when required, is beneficial to patients and healthcare systems by reducing hospital length-of-stay, providing cost savings, and improving patient satisfaction.
Abby C. Bradley   +4 more
doaj   +1 more source

Hospital at Home in 10 years—Here, borrow my binoculars

open access: yesJournal of Internal Medicine, Volume 300, Issue 2, Page 153-163, August 2026.
Abstract Hospital in the Home (HAH) refers to the delivery of acute hospital care to patients at home, or in their usual place of care, including nursing homes. HAH is an acute hospital substitution service—it delivers medical, nursing and allied health staff, skills, interventions and treatments, technologies and supervision usually found in hospitals
Michael Montalto
wiley   +1 more source

Risk factors for catheter related thrombosis during outpatient parenteral antimicrobial therapy

open access: yes, 2021
Background: Outpatient parenteral antimicrobial therapy (OPAT) delivery using peripherally inserted central catheters is associated with a risk of catheter related thrombosis (CRT).
Kilgarriff, Sinead   +17 more
core   +1 more source

Experience with liposomal amphotericin B in outpatient parenteral antimicrobial therapy [PDF]

open access: yes, 2021
Outpatient parenteral antimicrobial therapy (OPAT) is a safe, effective, and convenient treatment strategy for patients receiving intravenous antimicrobials in the outpatient setting; however, data are limited describing the use and safety of liposomal ...
Hamad, Yasir   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy